Myricetin protects pancreatic β-cells from human islet amyloid polypeptide (hIAPP) induced cytotoxicity and restores islet function

Abstract

The aberrant misfolding and self-assembly of human islet amyloid polypeptide (hiapp)-a hormone that is co-secreted with insulin from pancreatic β-cells-into toxic oligomers, protofibrils and fibrils has been observed in type 2 diabetes mellitus (t2dm). The formation of these insoluble aggregates has been linked with the death and dysfunction of β-cells. Therefore, hiapp aggregation has been identified as a therapeutic target for t2dm management. Several natural products are now being investigated for their potential to inhibit hiapp aggregation and/or disaggregate preformed aggregates. In this study, we attempt to identify the anti-amyloidogenic potential of myricetin (myr)- a polyphenolic flavanoid, commonly found in fruits (like syzygium cumini). Our results from biophysical studies indicated that myr supplementation inhibits hiapp aggregation and disaggregates preformed fibrils into non-toxic species. This protection was accompanied by inhibition of oxidative stress, reduction in lipid peroxidation and the associated membrane damage and restoration of mitochondrial membrane potential in ins-1e cells. Myr supplementation also reversed the loss of functionality in hiapp exposed pancreatic islets via restoration of glucose-stimulated insulin secretion. Molecular dynamics simulation studies suggested that myr molecules interact with the hiapp pentameric fibril model at the amyloidogenic core region and thus prevents aggregation and distort the fibrils. © 2020 walter de gruyter gmbh, berlin/boston 2020.